EMEA-001975-PIP01-16-M02 - paediatric investigation plan

Pimodivir

Key facts

• Active Substance:
  Pimodivir
• Therapeutic area:
  Infectious diseases
• Decision number:
  P/0003/2019
• PIP number:
  EMEA-001975-PIP01-16-M02
• Pharmaceutical form(s):
  Age appropriate oral solid dosage form
• Condition(s) / indication(s):
  Treatment of influenza
• Route(s) of administration:
  • Oral use
  • Gastric use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  03/01/2019

Decision

P/0003/2019: EMA decision of 3 January 2019 on the acceptance of a modification of an agreed paediatric investigation plan for pimodivir (EMEA-001975-PIP01-16-M02)

AdoptedReference Number: EMA/873049/2018